[Webinar] How molecular modeling can help scientists understand SARS-CoV-2 and design therapeutics
Delve into how comprehensive predictive science applications can improve structural understanding of viral proteins to design drugs and vaccines
Secure your place to explore how Dassault Systèmes is using molecular modeling for drug repurposing, detection of SARS-CoV-2 and vaccine designRegister
The discovery of suitable drugs that could help treat the SARS-CoV-2 virus is a long process – from understanding its epidemiology to resolving its molecular structures, understanding the mechanisms of its druggable protein targets, identifying effective therapeutic agents and finally developing vaccines to prevent further viral spread.
In this Pharma IQ webinar, Dassault Systèmes will analyze how computer-aided drug design, simulation and modular design therapeutics are essential analysis tools for speeding up drug development, driving innovation and crucially supporting life science experts in their research to treat the SARS-CoV-2 virus.
Anne Goupil-Lamy, BIOVIA Science Council Fellow at Dassault Systèmes, will present solution-driven case studies to help maximize drug development profitability and team collaboration.
Join your peers in this interactive webinar and come away with key lessons in how to:
- Leverage an open and scalable platform that brings together over 30 years of peer-reviewed research and world-class in silico techniques
- Understand the benefit of structure-based design workflows
- Increase your understanding of the role of structural vaccinology
- Enhance team collaboration by enabling researchers to better share their data and make better informed decisions in drug development
Sign up now to secure your free place.
Anne Goupil-Lamy, BIOVIA Science Council Fellow, Dassault Systèmes
The webinar will take place at:
- 7am PDT
- 10am EDT
- 3pm BST
- 4pm CET